Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:04:59 +0200Tue, 16 Jul 2024 16:07:00 +0200Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 19, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nucalaHuman medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 19, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nucalaTue, 16 Jul 2024 16:07:00 +0200Human medicineNucala : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-3860-steps-after_en.pdfNucala : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-3860-steps-after_en.pdfTue, 16 Jul 2024 16:03:00 +0200Human medicine